Director at PROCEPT (PRCT) granted RSUs and stock options

Rhea-AI Filing Summary

PROCEPT BioRobotics director Dan Puckett received new equity awards. He was granted 3,315 restricted stock units, each representing a right to one share of common stock, increasing his direct common stock holdings to 8,791 shares after the grant.

He was also granted stock options for 5,853 shares of common stock at an exercise price of $28.78 per share, expiring on June 8, 2036. Both the RSUs and options vest in full on the earlier of one year from the June 9, 2026 grant date or the next annual meeting, subject to continued service.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider PUCKETT DAN

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	5,853	$0.00	--
Grant/Award	Common Stock	3,315	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 5,853 shares (Direct, null); Common Stock — 8,791 shares (Direct, null)

Footnotes (1)

1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

Key Figures

RSU grant: 3,315 RSUs Shares held after grant: 8,791 shares Stock options granted: 5,853 options +3 more

6 metrics

RSU grant 3,315 RSUs Restricted stock units granted to director on June 9, 2026

Shares held after grant 8,791 shares Total common stock held directly after RSU award

Stock options granted 5,853 options Options on common stock granted to director

Option exercise price $28.78 per share Strike price for 5,853 stock options

Option expiration June 8, 2036 Expiration date of granted stock options

Vesting trigger 1 year or next meeting Earlier of one-year from June 9, 2026 or next annual meeting

Key Terms

restricted stock units (RSUs), Stock Option (Right to Buy), exercise price, grant, award, or other acquisition, +1 more

5 terms

restricted stock units (RSUs) financial

"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Stock Option (Right to Buy) financial

"The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of..."

exercise price financial

"conversion_or_exercise_price: "28.7800" for the stock option grant"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

vesting date financial

"subject to continued service through the applicable vesting date."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PUCKETT DAN

(Last) (First) (Middle)

150 BAYTECH DR.

(Street)

SAN JOSE CALIFORNIA 95134

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A(1)		3,315	A	$0	8,791	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$28.78	06/09/2026		A		5,853		(2)	06/08/2036	Common Stock	5,853	$0	5,853	D

Explanation of Responses:

1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

2. The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

Remarks:

	/s/ Jonathan Stone, Attorney-in-Fact for Dan Puckett	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did PROCEPT BioRobotics (PRCT) report for Dan Puckett?

Dan Puckett received equity awards in PROCEPT BioRobotics common stock. He was granted 3,315 restricted stock units and stock options for 5,853 shares, both awarded as compensation rather than open-market purchases or sales, and subject to future vesting conditions.

How many PROCEPT BioRobotics (PRCT) shares does Dan Puckett hold after this grant?

After the grant, Dan Puckett beneficially holds 8,791 shares of PROCEPT BioRobotics common stock directly. This figure reflects his updated position following the award of 3,315 restricted stock units, which will convert into shares only after they vest.

What are the terms of Dan Puckett’s stock options at PROCEPT BioRobotics (PRCT)?

Puckett received stock options for 5,853 shares of PROCEPT BioRobotics common stock at an exercise price of $28.78 per share. These options vest in full after specific service conditions and expire on June 8, 2036 if not exercised.

When do Dan Puckett’s RSUs and options in PROCEPT BioRobotics (PRCT) vest?

Both the 3,315 restricted stock units and the 5,853 stock options vest in full on the earlier of the one-year anniversary of the June 9, 2026 grant date or the next annual meeting, provided Puckett continues his service through the vesting date.

Were Dan Puckett’s PROCEPT BioRobotics (PRCT) awards open-market purchases?

No. The transactions are classified as grants or awards, not open-market purchases or sales. The RSUs and stock options were granted as compensation, with no cash price paid on grant and vesting dependent on continued service.